The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol plus metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin


Cakiroglu Y., Vural B. , Isgoren S.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.288, ss.213-220, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 288 Konu: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00404-013-2742-y
  • Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Sayfa Sayıları: ss.213-220

Özet

Polycystic ovary syndrome (PCOS) is considered as the most common endocrinopathy among women of reproductive age. Oral contraceptives (OCs) and metformin are one of the main drug groups in the long-term treatment of PCOS. This study was undertaken to investigate the effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ultrasonographic markers, body fat mass (BFM) index, leptin-ghrelin.